🦠 Making progress in complex diseases such as Crohn's 🧪 This is what our participating company BiOkuris - also a sister company of KiOmed Pharma and KitoZyme - is successfully doing. ✅ The drug BK003 is entering a clinical trial phase, the results of which are expected to improve the quality of life of patients suffering from Crohn's disease and irritable bowel syndrome (IBS)-type symptoms. The innovative product developed is a nutritional formulation comprising chitin glucan and an amalgam of essential vitamins and minerals. It seems clear that factors such as genetics, environment and immune system dysfunction play an important role. 🚀 This is the second clinical study conducted by Biokuris. The first involved a similar product, but targeted irritable bowel syndrome more strictly. 🔬 It's interesting to be working with Life Sciences companies like Biokuris, which are exploring other treatment, including medical nutrition. Well done to the teams for their determination in tackling complex health problems that remain unexplained to this day! Read the article in le d'écho. The link is bolow in the comments part. #lifesciences #medecine #nutritionmedicale Gery Lefebvre François Blondel
WE Life Sciences’ Post
More Relevant Posts
-
More than just a beautiful container for the human body, skin is our largest organ – and goes through a lot from season to season. Patients often forget that when it comes to outer health, there is no quick fix, so fostering habits for inner balance may be a useful strategy. While the relationship between gut and skin health continues to be an emerging area of research, Integrative Therapeutics offers a variety of products formulated for gastrointestinal support.* 🌟 Berberine Complex: Formulated to support the healthy balance of bacteria*. 🌟 Pro-Biome: A daily probiotic with a proprietary blend of 10 probiotic strains to promote digestive and immune health*. 🌟 Y Formula™: An herbal formula that supports healthy microbial balance* . *These statements have not been evaluated by the Food & Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease
To view or add a comment, sign in
-
In pharmacology class we had to do a summary about this article. It’s so interesting and important for our health to know how food influence our body. MDPI Nutrients MDPI https://lnkd.in/gQhjrjuC
To view or add a comment, sign in
-
🚀 New Research Alert! 🚀 *ALLAHAMDULLIHA* *Published in JPTCP* Thrilled to share our study on the combined effects of Vitamin B (B6, B9, B12) and Potassium in stroke prevention, published in The Journal of Population Therapeutics and Clinical Pharmacology! 🧠✨ *By Consultant Dietitian Imran Nawaz Bhatti, this research opens new doors in health science. 🌟* https://lnkd.in/eGk7HiEV Complete Research Paper 📜 available here👆👆👆 #Research #HealthBreakthrough #VitaminB #Potassium #StrokePrevention #Health #Wellness #Nutrition #Breakthrough #Research #ScienceNews #StrokePrevention #VitaminB #Potassium #Dietitian #HealthScience #ClinicalResearch #InnovativeHealth
To view or add a comment, sign in
-
Microbiome Therapeutic Potential In Treating Women's Chronic Pain #Mysummary I have experienced this from very close and how it can literally stop someone's life, endometriosis. It is a condition affecting millions of women, and often brings severe, chronic pain - even after surgery. But there is hope in the #microbiome. 🔹A recent survey of over 2,600 individuals with endometriosis across 51 countries revealed that 83% of respondents had modified their diets in an attempt to alleviate symptoms. 🔹About 63% reported a reduction in pain after making dietary changes, particularly by going gluten-free or dairy-free. 🔹The gut microbiome’s metabolites - chemical byproducts of bacterial processes - could significantly influence pain perception. Bile acids and short-chain fatty acids produced by gut bacteria can interact with the nervous system, even crossing the blood-brain barrier to alter the perception of pain at its very source. John Cryan 🔹Clinical trials are now underway to explore whether probiotics and antibiotics could offer sustained relief for chronic pain conditions. For example, two small randomized trials showed that certain Lactobacillus strains may reduce painful periods in people with endometriosis. #Mythoughts Chronic pain is highly individualized. One-size-fits-all approaches are unlikely to work, as pain is deeply personal and influenced by multiple factors, from genetics to environmental stressors. To make real progress, we need a more targeted approach that accounts for individual variations in gut microbiome composition and pain pathways. HAPPY to hear your THOUGHTS and stay POSITIVE! #Myinspiration "Hope is being able to see that there is light despite all of the darkness." – Desmond Tutu Link to the paper here: https://lnkd.in/eZZWuUp4 #microbiome #science #biology #health #pharma #diet #nutrition #probiotics #therapeutics #startup #biotech
To view or add a comment, sign in
-
#TechnologyTuesday 𝗗𝗶𝗮𝗴𝗻𝗼𝘀𝘁𝗶𝗰 𝗮𝘀𝘀𝗮𝘆 𝗳𝗼𝗿 𝗱𝗲𝘁𝗲𝗿𝗺𝗶𝗻𝗮𝘁𝗶𝗼𝗻 𝗼𝗳 𝗽𝗲𝗿𝘀𝗼𝗻𝗮𝗹 𝗺𝗶𝗰𝗿𝗼𝗯𝗶𝗮𝗹 𝗺𝗲𝘁𝗮𝗯𝗼𝗹𝗶𝘁𝗲 𝗽𝗿𝗼𝗱𝘂𝗰𝘁𝗶𝗼𝗻 𝗽𝗿𝗼𝗳𝗶𝗹𝗲 𝗳𝗼𝗿 𝗻𝘂𝘁𝗿𝗶𝘁𝗶𝗼𝗻𝗮𝗹 𝗮𝗱𝗷𝘂𝘀𝘁𝗺𝗲𝗻𝘁 🔺#Microbiome #imbalances, also known as #dysbiosis, have a profound impact on human health by affecting the production of bacterial metabolites that influence #immunity, #inflammation, and #chronic #diseases. Guided nutritional adjustments have proven impact on microbiome balances and thus human health. Most state of the art methods for #gut #microbiome profiling are often costly and time-consuming, relying on whole genome sequencing. 🔬 Scientists at the Experimental and Clinical Research Center (ECRC) and Max Delbrück Center (MDC) have developed an innovative #diagnostic #assay for targeted #microbiome #profiling from stool samples. This assay allows for the targeted measurement of gut microbiome metabolite production capacity for key metabolites, such as short-chain fatty acids (SCFA), trimethylamine-N-oxide (TMAO), and indoxyl sulfate (IS). The data can be used to tailor nutritional adjustments that may improve health outcomes. 💡 Validated in patient cohorts and nutritional challenges, this technology is poised to significantly #enhance the #precision of #dietary #recommendations, potentially improving outcomes in chronic kidney disease (#CKD) and other conditions related to gut dysbiosis. The assay's robust and reproducible protocol compared with its cost- and time effectiveness makes it a valuable tool for both clinical and research applications. 🔎 Learn more about this #technology on our website: https://lnkd.in/deiuCzqM 📰 Paper: https://lnkd.in/dYcSFtHE, https://lnkd.in/ddD4w4Nb #personalizednutrition #bacterial #metabolites #qRTPCR #chronicdiseases #inflammatorydiseases
To view or add a comment, sign in
-
🔬🧫🧬 Chronic inflammation underlies the pathology of numerous human diseases, including rheumatoid arthritis and inflammatory bowel diseases (IBD). 👩⚕️ The resolution of inflammation is an active process that is facilitated by specialized pro-resolving mediators (SPM) and their intermediate lipid mediators (LM). These LM derive endogenously from omega-3 polyunsaturated fatty acids (n-3 PUFA) and confer their inflammation-resolving effects. 🧬 Importantly, LM biosynthesis is dysfunctional in various conditions, which may explain the inconclusive efficacy data from n-3 PUFA interventions. Here, we conceived a synbiotic strategy to improve n-3 PUFA conversion to LM through microbial metabolism. 👨🔬 In summary, we have developed and tested a novel synbiotic strategy that holds promise for enhancing inflammation medicine as well as nutritional therapies, as it allows for the self-sufficient production of pro-resolving LM. 🧫 SynΩ3 and similar compositions have widespread application and formulation capabilities, above all in the treatment or prevention of conditions related to chronic inflammation. 🎤 To find out more, meet Bodo Speckmann from Evonik Germany at the 17th IPC2024 in Prague, 18-21 June 2024 and... Hit the bell 🔔🔔🔔 to stay tuned on to International Scientific Conference on #Probiotics, #Prebiotics, #Gut #Microbiota and #Health - #IPC2024 and get updated on probiotic, prebiotic #science and #microbiota #research.
To view or add a comment, sign in
-
◾️DETOXIGENOMIC DNA 🧬 TESTING◾️ 📍 @projectwellbeingllc @seanfreitas_elitecoaching Customized IV’s and pharmaceutical grade supplementation based upon your individualized results through our physician and sports science team. The DetoxiGenomic Profile test is a specialized genetic test designed to assess an individual’s ability to detoxify various toxins and chemicals. This test analyzes specific genetic polymorphisms (variations) that are associated with detoxification pathways in the body. Here are some key aspects of the DetoxiGenomic test: 1. Purpose: The test is intended to identify genetic variations that can influence the efficiency of detoxification enzymes. Understanding these variations can help healthcare providers develop personalized strategies to improve detoxification and overall health. 2. Genes Analyzed: The test typically includes analysis of genes involved in Phase I and Phase II detoxification pathways. These genes encode enzymes such as cytochrome P450 (CYP) enzymes, glutathione S-transferases (GST), and others. 3. . Personalized Recommendations: The test results can guide personalized recommendations for diet, lifestyle changes, and supplementation to enhance detoxification pathways and mitigate the impact of environmental toxins. Work with our team of health professionals to optimize your health and performance 🧬. Call/Text 📲 (702-525-7791) To schedule your advanced blood and DNA testing today! 🎥 @crossxfilms - #onepercentclub #professional #athletes #cbd #bodybuilder #IV #medicine #hyperbaricoxygentherapy #hyperbaricchamber #brainhealth #workout #workoutmotivation #recovery #health #healthylifestyle #wellness #performance #gym #gymmotivation #vegas #lifestyle #explorepage #biohacking - - By watching this video, you automatically consent to our disclaimer: ‘Disclaimer: The medical opinions and advice shared in this post are for entertainment purposes only and should not be considered as professional medical advice.
◾️DETOXIGENOMIC DNA 🧬 TESTING◾️
To view or add a comment, sign in
-
Vedic Lifesciences is your trusted partner for a wide range of services tailored to meet your clinical trial needs. Whether you're looking for Clinical or Pre-clinical studies, we've got you covered. Meet our CEO, Jayesh Chaudhary at one of the largest probiotic event, #Probiota2024 While you're at the show, please drop by our poster presentation that talks about our recently published paper in collaboration with Biom Pharmaceutical Corporation, a US-based probiotic company. Our trial focused on women's health, specifically evaluating a probiotic vaginal suppository designed to support vaginal health and maintain optimal pH levels. We look forward to sharing our findings with you. Here’s a glimpse of the health areas we offer: -Energy & Sleep -Men's Health -Women's Health -Cardio Endurance -Glucose Metabolism -Joint Health -Healthy Ageing -Vascular Health -Gut Health -Weight Management -Pre-clinical and Toxicity Studies -Skin and Eye Health -Cognition -Sports Nutrition We are excited to connect with you and explore how our expertise can support your health and research goals. #tradeshow #clinicalresearch #clinicaltrials #posterpresentation #Probiota2024 #IPA
To view or add a comment, sign in
-
FINRISK Cohort: Gut Microbiota's Role in Fracture Risk, A 7043 Patient Study! #Mysummary This new study explores the relationship between gut microbiota composition and the risk of fractures in a large Finnish cohort. The researchers analyzed data from 7,043 participants, with a median follow-up of 18 years, during which 1,092 incident fractures were recorded. Here is what they found: Individuals with higher alpha diversity in their gut microbiota had a lower risk of fractures. In contrast, differences in beta diversity were also linked to fracture risk. A higher relative abundance of Proteobacteria, especially Gammaproteobacteria, was associated with an increased risk of fractures. This association was observed across several genera, including Escherichia, Shigella, and Klebsiella. Interestingly, Tenericutes, a lesser-known phylum, was linked to a reduced risk of fractures. The protective effect may be due to their association with butyrate metabolism, known for its bone and muscle health benefits. The study also found that gut bacteria involved in amino acid metabolism and lipopolysaccharide biosynthesis are linked to fracture risk, suggesting metabolic pathways may mediate these effects. #Mythoughts While the study offers valuable insights into the gut-bone axis, it has limitations. The cohort is primarily of North European descent, which may limit generalizability. The study's observational nature means causality cannot be established. HAPPY to hear your THOUGHTS and stay POSITIVE! #Myinspiration “Try to be a rainbow in someone's cloud.” Maya Angelou Link to the paper here: https://lnkd.in/eQhVEH5g #microbiome #science #biology #health #pharma #diet #nutrition #probiotics #therapeutics #startup #biotech
To view or add a comment, sign in
2,244 followers
To read the article https://www.lecho.be/entreprises/pharma-biotechnologie/BiOkuris-veut-soulager-les-patients-atteints-de-la-maladie-de-Crohn/10535622